chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His symptoms began with dizziness about once a week.  The spells seemed minor at the time and was very random so we thought it might be related to his growth spurts.  This child never complains so as the dizzy spells got worse he just dealt with them without letting us know how frequent they were.  When he got concerned and aggravated that the spells were daily and sometimes multiple times a day he asked me to call the doctor.  We saw Dr. at the clinic and he referred us to a cardiologist.  Cardiologist did mention that he has seen similar symptoms following vaccinations. He performed multiple tests and seemed to think his heart was fine so he sent us home.  About this time, his symptoms worsened again and starting affecting his martial arts training. The dizzy spells seemed to worsen with cardio and then he experienced an blood pressure drop that caused convulsions and blacking out.  We were treated at the ER but all they would treat was a panic attack. He did NOT have just a panic attack.  Dr was consulted again and he performed a stress test and started patient on blood pressure medications.  After trying different prescriptions and natural suggestion from Dr, he was given a diagnosis of POTS.  We decided to reach out to a doctor who has worked with vaccine injuries.  Many tests were ordered one of which included heavy metal testing. Now we also have a Heavy Metal Toxicity diagnosis.  These symptoms despite treatment have not gotten better but have continued to progress.  His hands now tremor so badly that he cannot perform certain tasks easily.  Even something as simple as buttoning his shirts is frustrating.  Doable but frustrating.  He has had to give up part of his martial arts and struggles with what he continues to train for.  Dizzy spells, loss of vision, hand tremors, stomach upset, and headaches are all things that patient deals with on a weekly and daily basis.
Muscle soreness at the injection site; Extreme equilibrium issues / Dizziness / Any movement would cause him to feel dizzy; Extreme equilibrium issues / Dizziness / Any movement would cause him to feel dizzy; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th October 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 17th October 2020, 3 days after receiving Shingrix, the patient experienced dizziness and equilibrium trouble. On an unknown date, the patient experienced injection site muscle pain. On 16th November 2020, the outcome of the dizziness and equilibrium trouble were recovered/resolved. On an unknown date, the outcome of the injection site muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the dizziness, equilibrium trouble and injection site muscle pain to be related to Shingrix.  Additional details were received as follows: The patient received the vaccine in the upper right arm. The patient reported that, he experienced extreme equilibrium issues, dizziness and muscle soreness at the injection site after receiving Shingrix vaccine. He experienced the equilibrium problems and dizziness for four weeks and it recently went away and the soreness was still there, but not as bad as it was. He also reported the area was not red nor was it infected. He stated that, any movement would cause him to feel dizzy. He visited the emergency room and had tests done, including a CAT scan (computerized tomogram) but they were not able to find anything. He was not admitted into the hospital because they did not find anything that warranted the admission. He had also visited a therapist and was tested for vertigo but he did not have it. He sometimes walked with a walker and or cane, but he as able to walk freely without any problems. His doctor is aware of these adverse events. The patient consented to follow up with his doctor and provided the contact information.
extreme itching, over heated with fever, extreme chills and sickness. had to call an ambulance and go to emergency room
Pt has completely lost the hearing in her left ear, this happened approximately 4 weeks after receiving her first Shingrix immunization..
Woke up day after receiving vaccine, felt dizzy, had high blood pressure, later in the day and the day after patient noticed swelling in arm.
The only adverse reaction to the vaccine was some left should soreness.  I did not have any reactions to the two previous Pfizer Vax or the first booster.  However, two days later on 4/14 I developed body aches all over to include a non productive nuisance cough along with the beginning s of a sore throat.  The body aches went on two days.  4/14 and 15.  My sore throat got worse with it being sore to swallow on 4/16 and I had body temps between 99.2 and 101.  The body aches went away on 4/16  The sore throat started to clear on Sunday 4/16 and I have had no temp. since 4/16.  There is some residual nose congestion and an occasional cough with some mucus.
Pt recvd vax & exp swelling of arm, urticarial rash, dyspnea, & was disoriented; exam in ER, very anxious & would not lie down because os SOB; poss allergic react; VS nl x/for hypertension 170/100; skin shows a large bruise;
Patient given adult dose of Hepatitis A vaccine, not pediatric. Have left several messages at home and family has not returned calls.
I was quite sick for two days, aches, pains and headaches - unable to work. On third day my left armpit swelled up to the size of a grapefruit and subsided over the course of two days. I had a previous case of COVID-19 in late October 2020 for 2 weeks, fever, aches, night sweats, lowered pulse ox levels, lost 12 pounds it took about 8 weeks to fully recover from it.
Information has been received from an office manager concerning a female who on 19-NOV-2007 was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) inadvertently instead of zoster vaccine live (Oka/Merck). No problems were reported. The reporter confirmed that this was not a case of product confusion. No further details were available. There was no product quality complaint. Additional information has been requested.
pt recv vax SEP96 & pt was taking no other med & had no other concurrent conditions;DEC96 pt showed a lack of serconversion p/had a varicella antibody test;
At approximately 4:30 PM on 9-8-13, Pt became noticeably pale, clammy, and complained of "stomach pain" after receiving the fourth vaccination shot out of a total of five for the day (order given: hepatitis A, HPV, Meningitis, Tdap, and Varicella). He was quickly assisted to a reclining chair and given water and crackers as legs were elevated. BP 100/62, pulse 68, and pulse ox 97%. Episode lasted for 30 minutes, but patient recovered and was sent home.
I had headache that last for 6 days and really bad for only 1 day. I have fever and chills. On the 31st of Jan 2021 I had a very painful pain on my left side. The pain stayed there for 5 days. The pain interfered with my daily life. It hurted really when I moved, so I tried to stay still. By time my appointment, I was doing fine. But my doctor wanted me to come in to be on the safe side, since I am a kidney patient. I have kidney problems so I thought the shot may have caused something so I reached out to my kidney doctor. He had me to come in on 02/9/2021 to do a check up and everything was fine.
The patient received her first dose of the COVID-19 vaccin (Pfizer). Standard dose was administered with no adverse reaction at first. Patient states later in the evening she began to notice swelling in her left arm, an area on her left thigh, redness on left side of face, and a headache. The same swelling was noted the next day. She called the pharmacy in the afternoon on Saturday 9/11/21 to inquire about the reaction and what she should do.  I recommended taking tylenol, using cold compresses, and calling her physician. With her permission, I called her on Tuesday 9/14/21 at which time she stated that the swelling had gone down as of mid day Monday 9/13/21, but headache is still present. She also stated that she called her doctor, but had not responded back to her.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were unknown. On multiple unspecified dates, the patients were administered improperly stored PROQUAD (dose and route unknown, lot # M029598, expiration date: 10-DEC-2017). The vaccines were exposed to 7.5 Fahrenheit degree for 15 hours. There were no previous excursions. There was no data logger. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt received a flu vaccine (unknown name) high in the left shoulder. She developed severe pain and restriction in ROM of the shoulder a couple of days later. SXs have persisted, causing her to seek medical treatment for the shoulder pain. Denies any injury to the shoulder prior to this.
This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Ankle Redness) and SWELLING (swelling after the 2nd shot) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Ankle Redness) and SWELLING (swelling after the 2nd shot). At the time of the report, ERYTHEMA (Ankle Redness) and SWELLING (swelling after the 2nd shot) had resolved.            Events resolved after one month later.  No concomitant medications was reported. No treatment was reported.   This case was linked to MOD-2021-374891, MOD-2021-374741 (Patient Link).
2 hours after receiving vaccine I had a terrible headache which was gone the next morning, took 2 Tylenol. When I woke up the next morning I had aches and pains in neck, shoulders, hips, and ankles, then that afternoon started with a cough. The next day coughing followed by secretions from nose. Never ran a fever, the next day secretions were out of control as well as coughing. The next morning which was December 6th went to local Hospital Urgent care was seen and diagnosed with acute bronchitis. Out on azithromycin. By Wednesday I was worse, lot of head pain and sinus pain lots of secretions. Called hospital and spoke with a nurse who talked to the same doctor I saw on Monday was given a prednisone step down pack and Bromfed which helped for about two days. By Saturday the secretions were worse again. On December the 19th finally went back to hospital and was given Amoxicillin, Bromfed, Flonase and eye drops and also given a shot of Decadron as my eyes were matting shut.
Patient was seen for leg swelling and treated for leg edema. The patient denies having shortness of breath, chest pain, discomfort with inhalation.
pt recvd vax & 23JUN93 & immed felt burning sensation on tongue, throat became sore on swallowing; seen by MD on 24JUN93; red, sore throat;
TOOK TWO UNREFRIGERATED DOSES OF VIVOTIF; This case (PVX2019-2185) was received form a consumer on 27-Aug-2019. It described a female consumer, who "took two unrefrigerated doses of Vivotif" (PT: Product storage error), while being on Vivotif for an unknown indication.  Case report: The consumer took two doses of Vivotif that had not been refrigerated and were no longer good to use. The second dose was taken on 27-Aug-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two unrefrigerated doses of Vivotif" was considered as not applicable.
Immediate pain and bruising at injection site, persistent pain worse with movement c/w SIRVA
Information has been received from a registered nurse concerning a 42 year old female patient who on an unspecified date was vaccinated with MMR II. It was noted that on an unspecified date the patient had a negative rubella titer. The patient's vaccination history was unknown. Medical attention was sought in the office. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. No further information is available.
Pain; Massive headache; Low grade fever; Nausea; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Pain), HEADACHE (Massive headache), PYREXIA (Low grade fever) and NAUSEA (Nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced PAIN (Pain), HEADACHE (Massive headache), PYREXIA (Low grade fever) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (Pain), HEADACHE (Massive headache), PYREXIA (Low grade fever) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.
Patient reports baseball size mass/lump to left axillary/breast area 1 day after vaccine administration. Patient states lump was sore and tender and pain aggravated by movement of left upper extremity. Lump is progressively getting smaller.
Information has been received from a physician concerning a female pt who was vaccinated with a 2nd dose of Hep-B vaccine recombinant (yeast). Subsequently, the pt experienced an anaphylactic reaction and was hospitalized. No further information was provided. Additional information has been requested. F/U states: Information has been received from a physician concerning a 12 year old female pt with severe asthma and environmental allergies who was vaccinated with a 2nd dose of Hep-B. He indicated that about 1 1/2 hours after receiving the vaccine, she went into cardiac arrest, was resuscitated and transported to the hospital. The pt was intubated and placed on a ventilator for several days. The physician stated that the child is fine now and has had follow-up visits to the clinic. It was noted that the physician "did a skin test to Recombivax in the clinic and the results were positive". Additional information has been requested.
extreme nausea, heart palpitations, sweating (first night).  Weekly bouts of nausea, reduced appetite, weight loss,  difficulty waking up, brain fog.
two missing vials were given without being reconstituted; two missing vials were given without being reconstituted; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, there were 4 vials of Shingrix antigen in the fridge and 2 vials of adjuvant were found left out on the counter. Two adjuvant vials were missing.  The reporter initially stated that it was possible that the two missing vials were given without being reconstituted, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The situation was still being investigated.  After specialist noted the safety team would be informed of the potential administration of the adjuvant-only, the reporter back-pedaled and stated that it was more likely the box got dropped and the adjuvant vials were lost or discarded.  The specialist was submitting potential event out of an abundance of caution. The reporter did not consent to follow-up.
The wrong pfizer vial was grabbed from the refrigerator and an undiluted pediatric pfizer dose was administered to an adult. When the wrong vial was drawn up, the regular pfizer vaccine label was attached to the syringe. Pt received less than the recommended 30mcg per dose of the adult vaccine. Based on CDC Interim Clinical Considerations, we told the patient that he can return for a repeat dose today. Pt said he will come back tonight.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Physician). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Jul2022 as DOSE 4 (BOOSTER), SINGLE (lot number: FP7135) at the age of 47 years old, administered in the left arm for COVID-19 immunization; Covid-19 vaccine (COVID-19 VACCINE), as DOSE 1, SINGLE (batch/lot number: unknown), as DOSE 2, SINGLE (batch/lot number: unknown) and as DOSE 3 (BOOSTER), SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "Knowm allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19." The patient underwent the following laboratory tests and procedures: COVID-19 Test (SARS-CoV-2 test): Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of Drug ineffective, Covid-19.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to drug ineffectiveness and COVID-19 cannot be ruled out.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown demographics. On an unspecified date, since 05-MAY-2014 an unspecified number of patients were vaccinated with VARIVAX (Merck). The reporter stated that on 05-MAY-2014 onwards her refrigerator and freezer units began to have temperature excursions and VARIVAX (Merck) was improperly exposed to temperatures above 5F as listed in the following sentences. VARIVAX (Merck) Lot # K007783 (expiration: 28-MAY-2016) was improperly exposed to 22F for 144 hours. All of the data listed here was reconfirmed with the reporter. No further information was available at the time of this report. No product quality compliant was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Local redness at inj. site - was red, raised/swollen and sl warm - noted approx 24 hrs later (parents had not looked at area prior. Pt stated itchy. 24 hrs later still spreading - started on KEFLEX. Not improving 48 hrs later. Redness spreading seen at weekend access. Described as red 1.5 in pale border then serpiginous outer red ring. Abx stopped. Resolved on own. Also noted fine red rash facial/cheeks.
Seen 4/1 for fever 101 Dx with VUOs. Returned to office 4/4 due to Generalize rash all over maculopapular rash. Dx possible VROs vs rash due to immunes 10 days prior Covid neg
The patient accidentally received the 12 and up Covid vaccine instead of the 5-11 Covid vaccine.  Patient does not have any symptoms.
pt came in w/lesions on chest, neck, upper extremities, trunk (total of 10-15 pox) 11 days p/vax; inj site swollen & extremely red;
Pfizer vaccine diluted with 0.8 ml of sodium sodium chloride instead of 1.8 ml of sodium chloride. Patient contacted and notified of event. NO patient harm or adverse reactions noted. Advised to seek medical attention if needed. patient verbalized understanding
The following day my left arm was covered in a rash. Each day the rash progressed and covered both arms, torso, neck and legs. The rash continued breaking out until approximately April 24. As of May 5, there are still a few spots and itchy areas remaining.  My Arthritis clinic recommended stopping my Humera until rash resolved. My primary care doctor recommended report rash to Maderna. No office visits were done.
Developed severe pain post injection at injection site that progressively worsened and subsequently developed neurological symptoms of numbness and tingling with decreased grip of right hand.  Now symptoms are spreading to chest and contralateral shoulder
Pt had vasovagal attack with questionable convulsion after administration of all 4 vaccines (as witnessed by medical assistant and NP). Pt recovered with observation and after lying down.
received the pediatric dose for dose 1 of the series although was already 12 years old
Right after I got the shot within 2 minutes my whole mouth and throat became immediately dry. It lasted about 20 minutes. I did talk the EMT and doctor at the vaccine site before leaving and was asked to wait an additional 45 minutes before leaving by doctor.
Pfizer-BioNTech COVID-19 Vaccine EUA: presented with acute hypoxemic respiratory failure secondary to COVID pneumonia. Received steroids, remdesivir, baricitnib, anticoagulation,. and antimicrobials and discharged medically stable.
A report was received from a health care professional on 10/24/2002, concerning a 37 year old female vaccinee and approximately 10 other staff who inadvertently received Fluvirin subcutaneously in 10/2002. In October 2002, the vaccinee and approximately 10 others experienced inadvertent administration of Fluvirin receiving 0.5ml of Fluvirin Subcutaneously with 5/16 inch needles. No adverse event was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment.
got sick; he was dead; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 02Jan2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer.), for COVID-19 Immunization. The following information was reported: DEATH (death, medically significant) with onset 14Jan2023, outcome "fatal", described as "he was dead"; ILLNESS (non-serious), outcome "unknown", described as "got sick". The event "he was dead" required emergency room visit. The patient date of death was 14Jan2023. The reported cause of death was unknown. It was not reported if an autopsy was performed. Details were as follows: Patient received the shot on 02Jan2023, and by the 14Jan2023, he was dead. The reporter noted that when the patient first got sick (not further specified), he stayed over his friend's house, and reporter urged him to go to the emergency room.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: he was dead
Patient states she began experiencing leg and knee weakness.  Initially saw orthopedist who administered a cortisone shot.  When symptoms did not go away, she was referred to a neurologist who diagnosed transverse myelitis.
HEADACHE, CHILLS, FEVER, DIARRHEA,  AND FATIGUE